Atlas Trials

A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

Clinical trial NCT06555432 · RECRUITING

Trial details

NCT number
NCT06555432
Sponsor
Takeda
Status
RECRUITING
Study type
OBSERVATIONAL
Cytomegalovirus (CMV)
Start date
2024-11-14
Primary completion
2028-10-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.